Synthesis of S-licarbazepine by asymmetric reduction of oxcarbazepine with Saccharomyces cerevisiae CGMCC No. 2266

Journal of Molecular Catalysis B: Enzymatic

Volumn 72, Issue 3-4, 2011, Pages 294-297

  Ou, Zhi Min ^a   Shi, Han Bing ^b   Sun, Xing Yuan ^b   Shen, Wen He ^c  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c Zhejiang Jiuzhou Pharma Science and Technology Co Ltd   (China)

Author keywords

Asymmetric reduction; Biotransformation; Oxcarbazepine; S licarbazepine

Indexed keywords

ASYMMETRIC REDUCTION; BIOTRANSFORMATION; CO-SUBSTRATE; ENANTIOMETRIC EXCESS; IN-SITU; INITIAL CONCENTRATION; INITIAL PH VALUE; MEMBRANE REACTOR; OPTIMUM CONCENTRATION; OPTIMUM FLUX; OXCARBAZEPINE; PRODUCTION EFFICIENCY; REDUCTION CONDITIONS; REDUCTION PROCESS; S-LICARBAZEPINE;

BIOREACTORS; GLUCOSE; SYNTHESIS (CHEMICAL); YEAST;

SUBSTRATES;

GLUCOSE; LICARBAZEPINE; OXCARBAZEPINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; ASYMMETRIC SYNTHESIS; BIOMASS; ENANTIOMER; MEMBRANE REACTOR; NONHUMAN; PH; REACTION TIME; REDUCTION; SACCHAROMYCES CEREVISIAE; TEMPERATURE;

SACCHAROMYCES CEREVISIAE;

EID: 80052271346     PISSN: 13811177     EISSN: 18733158     Source Type: Journal    
DOI: 10.1016/j.molcatb.2011.07.004     Document Type: Article

References (24)

1. L. Almeida, and P. Soares-da-Silva Neurotherapeutics 4 2007 88 96
2. A. Parada, and P. Soares-da-Silva Neurochem. Int. 40 2002 435 440
3. G. Alves, I. Figueiredo, M. Castel-Branco, A. Loureiro, A. Falcão, and M. Caramona Anal. Chim. Acta 596 2007 132 140
4. M. Vaz-da-Silva, L. Almeida, A. Falcão, E. Soares, J. Maia, T. Nunes, and P. Soares-da-Silva Clin. Ther. 32 2010 179 192
5. G. Sierra-Paredes, A. Núñez-Rodriguez, A. Vázquez-López, T. Oreiro-García, and G. Sierra-Marcuño Epilepsy Res. 72 2006 140 146
6. E. Perucca, J. French, and M. Bialer Lancet Neurol. 6 2007 793 804
7. D. Milovan, L. Almeida, M.K. Romach, T. Nunes, J.F. Rocha, M. Sokowloska, E.M. Sellers, and P. Soares-da-Silva Epilepsy Behav. 18 2010 366 373
8. G. Sierra-Paredes, M.T. Oreiro-García, M.D. Vázquez- Illanes, and G. Sierra-Marcuño Epilepsy Res. 77 2007 36 43
9. C. Di Resta, P. Ambrosi, G. Curia, and A. Becchetti Eur. J. Pharmacol. 643 2010 13 20
10. F. Donati, G. Gobbi, J. Campistol, G. Rapatz, M. Daehler, Y. Sturm, and A.P. Aldenkamp Seizure 16 2007 670 679
11. J.S.E. Hellewell J. Affect. Disorders 72 2002 S23 S34
12. A.K. Kaddurah, and G.L. Holmes Epilepsy Behav. 8 2006 289 293
13. K. Linnet, A. Steentoft, K.W. Simonsen, A. Sabers, and S.H. Hansen Forensic Sci. Int. 177 2008 248 251
14. R.M. Stepanović-Petrović, M.A. Tomić, S.M. Vučković, G. Poznanović, N.D. Ugrešić, M.Š. Prostran, and B. Bošković Pharmacol. Biochem. Behav. 97 2011 611 618
15. M.A. Tomić, S.M. Vučković, R.M. Stepanović- Petrović, N. Ugrešić, M.Š. Prostran, and B. Bošković Pain 111 2004 253 260
16. J. Sawynok, A.R. Reid, and B.B. Fredholm Neurosci. Lett. 473 2010 178 181
17. W. Martinez, A. Ingenito, M. Blakeslee, G.L. Barkley, K. McCague, and J. D'Souza Epilepsy Behav. 9 2006 448 456
18. M. Mazza, G. Della Marca, M. Di Nicola, G. Martinotti, G. Pozzi, L. Janiri, P. Bria, and S. Mazza Epilepsy Behav. 10 2007 397 401
19. E.B. Kurbanoglu, K. Zilbeyaz, M. Ozdal, M. Taskin, and N.I. Kurbanoglu Bioresource Technol. 101 2010 3825 3829
20. S. Bräutigam, D. Dennewald, M. Schürmann, J. Lutje-Spelberg, W.-R. Pitner, and D. Weuster-Botz Enzyme Microb. Technol. 45 2009 310 316
21. T. Ema, H. Yagasaki, N. Okita, M. Takeda, and T. Sakai Tetrahedron 62 2006 6143 6149
22. B.B. Zhang, W.Y. Lou, M.H. Zong, and H. Wu J. Mol. Catal. B: Enzym. 54 2008 122 129
23. T. Matsuda, Y. Yamagishi, S. Koguchi, N. Iwai, and T. Kitazume Tetrahedron Lett. 47 2006 4619 4622
24. Z. Ou, J. Wu, L. Yang, and P. Cen Korean J. Chem. Eng. 25 2008 124 128